Finance

Lists
600572:SHA
Zhejiang CONBA Pharmaceutical Co., Ltd.
4,33 CN¥
+1,41%
(+0,060) 1D
19 қаз., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600572...
Open
4,24 CN¥
High
4,35 CN¥
Low
4,24 CN¥
Mkt. cap
10,85 млрд
Avg. vol.
42,32 млн
Volume
37,98 млн
Dividend
3,46%
Quarterly dividend
0,04 CN¥
Ex-dividend date
2026 ж. 24 мау.
P/E ratio
21,61
52-wk high
5,17 CN¥
52-wk low
3,77 CN¥
EPS
0,20 CN¥
Shares outstanding
2,67 млрд
No. of employees
8 мың
Open
4,24 CN¥
High
4,35 CN¥
Low
4,24 CN¥
Mkt. cap
10,85 млрд
Avg. vol.
42,32 млн
Volume
37,98 млн
Dividend
3,46%
Quarterly dividend
0,04 CN¥
Ex-dividend date
2026 ж. 24 мау.
P/E ratio
21,61
52-wk high
5,17 CN¥
52-wk low
3,77 CN¥
EPS
0,20 CN¥
Shares outstanding
2,67 млрд
No. of employees
8 мың
News stories
From web sources and news partners
Kalkine Media
Kalkine Media
·
1 сағат бұрын
Ardagh Metal Packaging (NYSE:AMBP): What Comes Next?
Simply Wall Street
Simply Wall Street
·
50 минут бұрын
Meta (META) Faces Fresh Privacy Scrutiny Over AI Smart Glasses
Yahoo Finance
Yahoo Finance
·
23 сағат бұрын
Michael Burry Warns of a Stock Market ‘Supervolcano’
About Zhejiang CONBA Pharmaceutical Co., Ltd.
CEO-
Employees7,83 мың
Founded1969
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,62 млрд
1,50 млрд
1,91 млрд
1,80 млрд
Cost of goods sold
735,74 млн
751,67 млн
824,28 млн
786,71 млн
Cost of revenue
735,74 млн
751,67 млн
824,28 млн
786,71 млн
Research and development expenses
63,93 млн
78,49 млн
49,23 млн
62,51 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
635,30 млн
611,75 млн
751,80 млн
688,94 млн
Operating expense
718,20 млн
701,12 млн
825,90 млн
777,06 млн
Total operating expenses
1,45 млрд
1,45 млрд
1,65 млрд
1,56 млрд
Operating income
163,29 млн
45,06 млн
255,33 млн
231,98 млн
Other non operating income
-12,05 млн
-234,68 м.
-4,03 млн
1,79 млн
EBT including unusual items
268,24 млн
-51,57 млн
249,08 млн
225,65 млн
EBT excluding unusual items
167,94 млн
67,42 млн
266,37 млн
255,44 млн
Income tax expense
33,61 млн
53,06 млн
46,05 млн
40,26 млн
Effective tax rate
12,53%
-102,87%
18,49%
17,84%
Other operating expenses
19,42 млн
13,93 млн
22,15 млн
21,98 млн
Net income
230,43 млн
-109,67 млн
198,45 млн
179,32 млн
Net profit margin
14,25%
-7,32%
10,41%
9,99%
Earnings per share
-
-
-
-
Interest and investment income
20,29 млн
26,12 млн
4,64 млн
41,65 млн
Interest expense
-1,91 млн
-1,77 млн
-1,50 млн
-528,12 м.
Net interest expenses
18,38 млн
24,35 млн
3,14 млн
41,13 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
246,75 млн
128,05 млн
338,33 млн
314,43 млн
Gain or loss from assets sale
6,34 млн
-4,89 млн
-
-522,49 м.
AI content may include mistakes. Learn more
Google қолданбалары